FinnCap Reaffirms “Corporate” Rating for ANGLE (LON:AGL)

FinnCap reaffirmed their corporate rating on shares of ANGLE (LON:AGL) in a research report sent to investors on Wednesday, June 26th, ThisIsMoney.Co.Uk reports.

Shares of LON:AGL traded up GBX 2.50 ($0.03) during midday trading on Wednesday, hitting GBX 68.50 ($0.90). The company’s stock had a trading volume of 154,349 shares, compared to its average volume of 106,228. The firm has a market capitalization of $117.40 million and a PE ratio of -10.07. The stock’s 50 day moving average is GBX 63.53. ANGLE has a fifty-two week low of GBX 38 ($0.50) and a fifty-two week high of GBX 79.80 ($1.04).

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others.

Further Reading: What is the float in trading stocks?

Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.